We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Groupe Crit | EU:CEN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 0.54% | 74.00 | 73.80 | 75.60 | 75.60 | 73.80 | 75.60 | 2,943 | 02:01:03 |
RNS Number:5565Q CeNeS Pharmaceuticals PLC 06 October 2003 CENES PHARMACEUTICALS PLC (the "Company") Director(s) Shareholding The Company was today informed that Mr Alan Goodman, Chairman of the Company, purchased on the 3 October 2003, 250,000 ordinary shares of 1p each in the Company ("Ordinary Shares") for 4.5 pence per share. Following this purchase Mr Goodman has a beneficial interest in 14,400,533 Ordinary Shares, representing 6.8 per cent of the current issued share capital of the Company. 6 October 2003 This information is provided by RNS The company news service from the London Stock Exchange END RDSUNUAROWRRRAA
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions